PSA Response to Neoadjuvant Androgen Deprivation Therapy (NA-ADT) and Long-Term Cancer Outcomes in Men Treated with Definitive External Beam Radiotherapy (EBRT) and High Dose Rate Brachytherapy Boost (HDRBT)